Table 3 Main adverse events
From: Loxapine to control agitation during weaning from mechanical ventilation
Loxapine | Placebo | p Value | |
|---|---|---|---|
Shock, n (%) | 5 (10) | 6 (15) | 0.54 |
Unexplained fever, n (%) | 1 (2) | 0 (0) | 1.0 |
Seizure, n (%) | 1 (2) | 0 (0) | 1.0 |
Dyskinesia, n (%) | 0 | 0 |